1-4 of 4
Hermes Garban, MD PhD
Close
Sort by
Journal Articles

Overexpression of Raf Kinase Inhibitor Protein (RKIP) in Multiple Myeloma and Its Molecular Signature

Anna Shvartsur, Hermes Garban, MD PhD, Benjamin Bonavida, PhD
Journal: Blood
Blood (2016) 128 (22): 5673.
https://doi.org/10.1182/blood.V128.22.5673.5673
Published: 2016
Journal Articles

Yin Yang 1 (YY1) Acting Primarily As an Oncogene and Rarely As a Tumor Suppressor in Distinct Hematological Malignancies: Prognostic and Therapeutic Implications

Samantha Kaufhold, Stephanie Wottrich, Hermes Garban, MD PhD, Massimo Libra, MD Ph.D., Benjamin Bonavida, PhD
Journal: Blood
Blood (2016) 128 (22): 5122.
https://doi.org/10.1182/blood.V128.22.5122.5122
Published: 2016
Journal Articles

In silico Tissue-Based Expression Analysis of YY1 and Cancer Stem Cell (CSC) Transcription Factors in Hematological Malignancies: Unraveling New Therapeutic Targets

Samantha Kaufhold, Hermes Garban, MD PhD, Benjamin Bonavida, PhD
Journal: Blood
Blood (2015) 126 (23): 4814.
https://doi.org/10.1182/blood.V126.23.4814.4814
Published: 2015
Journal Articles

A Bioinformatics Approach Revealed a Differential Expression of RKIP-Related Genes in Pre-Multiple Myeloma and Multiple Myeloma: Clinical Implications

Anna Shvartsur, Devasis Chatterjee, PhD, Haiming Chen, MD PhD, James Berenson, MD, Hermes Garban, MD PhD, Benjamin Bonavida, PhD
Journal: Blood
Blood (2015) 126 (23): 5309.
https://doi.org/10.1182/blood.V126.23.5309.5309
Published: 2015